Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EAST BRUNSWICK, N.J., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that four scientific abstracts on pegloticase and two scientific abstracts based...
-
EAST BRUNSWICK, N.J., June 17, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Christopher Clement, President and Chief Executive Officer of Savient...
-
EAST BRUNSWICK, N.J., June 9, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that President and CEO Christopher G. Clement is a finalist for The New Jersey Ernst...
-
EAST BRUNSWICK, N.J., May 13, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, Senior Vice President, Commercial Operations of Savient...
-
EAST BRUNSWICK, N.J., April 16, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that the company will release financial results for the first quarter 2008...